Jian QinYuMD

Clinical Trials

• Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer Start of enrollment: 2007 Sep 01

  Completed

  Phase 1, Phase 2

• FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy Start of enrollment: 2007 Mar 30

  Terminated

  Not Applicable

• An Exploratory, Open Label, Single Center Study of [F-18]HX4 Start of enrollment: 2008 Jan 01

  Completed

  Early Phase 1

• Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody Start of enrollment: 2008 Mar 01

  Completed

  Phase 3

• Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 Start of enrollment: 2008 Aug 01

  Completed

  Early Phase 1

• An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037 Start of enrollment: 2009 Apr 01

  Completed

  Early Phase 1

• FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer Start of enrollment: 2010 Apr 01

  Active, not recruiting

  Not Applicable

• Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects Start of enrollment: 2011 May 01

  Terminated

  Phase 1

• PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer Start of enrollment: 2014 Feb 01

  Completed

  Not Applicable

• FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2016 Apr 20

  Active, not recruiting

  Phase 2

• FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy Start of enrollment: 2016 May 04

  Active, not recruiting

  Phase 2

• Join now to see all